Finance

Lists
Why is ELDN down 6.40%?
Dive Deeper
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
$1.90
-6.40%
(-0.13) 1D
$1.93
+1.58% (+0.030)
After hours
Closed: Nov 19, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
$2.05
High
$2.07
Low
$1.86
Mkt. cap
160.47M
Avg. vol.
929.05K
Volume
854.35K
52-wk high
$4.49
52-wk low
$1.35
EPS
-$0.77
Beta
0.95
Shares outstanding
84.46M
No. of employees
33
Open
$2.05
High
$2.07
Low
$1.86
Mkt. cap
160.47M
Avg. vol.
929.05K
Volume
854.35K
52-wk high
$4.49
52-wk low
$1.35
EPS
-$0.77
Beta
0.95
Shares outstanding
84.46M
No. of employees
33
News stories
From web sources and news partners
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteeledon.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELDN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current $1.90
$10.00 (+426.32%)
Average
$8.25 (+334.21%)
Lowest
$7.00 (+268.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Guggenheim
Buy
Maintained
$8.00
+321.1%
11/15/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$7.00
+268.4%
11/16/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$10.00
+426.3%
10/27/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$8.00
+321.1%
09/22/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$12.00
+531.6%
07/21/2026
Vamil Divan
Guggenheim
Buy
Maintained
$8.00
+321.1%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.49M
17.20M
18.23M
17.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.99M
3.98M
4.64M
3.91M
Operating expense
21.48M
21.18M
22.87M
21.67M
Total operating expenses
21.48M
21.18M
22.87M
21.67M
Operating income
-21.48M
-21.18M
-22.87M
-21.67M
Other non operating income
11.07M
-17.84M
-8.76M
17.74M
EBT including unusual items
-10.41M
-39.02M
-31.63M
-3.93M
EBT excluding unusual items
-10.41M
-39.02M
-31.63M
-3.93M
Income tax expense
35.00K
-
-
-
Effective tax rate
-0.34%
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.45M
-39.02M
-31.63M
-3.93M
Net profit margin
-
-
-
-
Earnings per share
-0.10
-0.33
-0.27
-0.03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps